Human Embryonic Stem Cells Global Market Report 2024

Description

Human embryonic stem cells (hESCs) are pluripotent cells derived from the inner cell mass of a blastocyst, an early-stage embryo. These cells possess the remarkable capability to differentiate into any cell type in the human body, making them immensely valuable for various research and therapeutic applications. The primary uses of hESCs include developing treatments for diseases and injuries by generating healthy tissue and studying disease progression and treatment in a controlled environment.

The main types of human embryonic stem cells are totipotent stem cells, pluripotent stem cells, and unipotent stem cells. Totipotent stem cells can differentiate into any cell type found in an embryo, including extra-embryonic tissues such as the placenta. The products derived from hESCs find applications in regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. These applications span across research, clinical trials, and other fields.

The human embryonic stem cells market research report is one of a series of new reports from The Business Research Company that provides human embryonic stem cells market statistics, including the human embryonic stem cells industry global market size, regional shares, competitors with the human embryonic stem cells market share, detailed human embryonic stem cells market segments, market trends, and opportunities, and any further data you may need to thrive in the human embryonic stem cells industry. These human embryonic stem cells market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The human embryonic stem cells market size has grown rapidly in recent years. It will grow from $1.13 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth observed in the historic period can be attributed to several factors, including increased funding and investments in stem cell research, regulatory approvals for research and clinical applications, heightened public awareness about stem cell therapies, the emergence of regenerative medicine as a field, and expanded clinical applications of stem cells in various medical treatments.

The human embryonic stem cells market size is expected to see rapid growth in the next few years. It will grow to $1.83 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The surge in the forecasted period's growth can be linked to various factors, including the rise in cell therapy production facilities, heightened demand for regenerative therapies, increased prevalence of cardiac and malignant diseases, progress in stem cell biology research, and enhanced awareness of the therapeutic potential of stem cells. Notable trends expected during this period encompass progress in regenerative medicine, a heightened emphasis on personalized medicine, expanding applications in drug discovery and toxicology, technological advancements, and the expansion of biobanking.

Government funding for regenerative medicine development is anticipated to drive the growth of the human embryonic stem cells market. Regenerative medicine aims to restore normal bodily function by repairing or replacing damaged tissues or organs. This sector is receiving increased government support due to factors such as the growing prevalence of chronic diseases and advancements in stem cell research. Human embryonic stem cells play a crucial role in regenerative medicine by offering potential therapies for tissue and organ repair. For example, the Canadian government allocated $45 million over three years, starting in 2022-23, to bolster stem cell and regenerative medicine research, indicating a strong commitment to this field.

Major players in the human embryonic stem cell market are expanding their focus to include diverse therapeutic applications, such as pluripotent stem cells for treating Parkinson's disease, in order to gain a competitive advantage. Pluripotent stem cells have the potential to generate dopaminergic neurons, which can help restore motor function by replacing lost dopamine-producing neurons. In October 2023, Bayer AG invested $250 million to establish its first Cell Therapy Manufacturing Facility in California, initially targeting BlueRock Therapeutics' bemdaneprocel derived from pluripotent stem cells for Parkinson's disease treatment. This facility, equipped with fully electric manufacturing capabilities, addresses the industry's need for increased regenerative medicine manufacturing capacity.

In February 2024, Charles River Laboratories International Inc., a US-based pharmaceutical company, partnered with Pluristyx Inc. to enhance its portfolio with high-quality embryonic stem cells (ES) and induced pluripotent stem cells (iPSCs). This collaboration enables Charles River to distribute Pluristyx's extensive line of ES and iPSC cell lines, including genetically engineered and disease state lines, to support therapeutic development. Pluristyx Inc., a US-based stem cell technology company, specializes in providing human induced pluripotent stem cells (iPSCs).

Major companies operating in the human embryonic stem cells market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KgaA, Astellas Pharma Inc., Lonza Group, PerkinElmer Inc., R&D Systems, LifeCell, Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, CellGenix GmbH, PeproTech Inc., Lineage Cell Therapeutics Inc., BioTime, Asterias Biotherapeutics Inc., ESI BIO, STEMCELL Technologies Inc., TATAA Biocenter, Celgene Corporation

North America was the largest region in the human embryonic stem cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human embryonic stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the human embryonic stem cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human embryonic stem cells market consists of sales of stem cell lines, stem cell media and reagents, and stem cell culture equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Embryonic Stem Cells Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human embryonic stem cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human embryonic stem cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human embryonic stem cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Totipotent Stem Cells; Pluripotent Stem Cells; Unipotent Stem Cells
2) By Product: Regenerative Medicine; Stem Cell Biology Research; Tissue Engineering; Toxicology Testing
3) By Application: Research; Clinical Trials; Other Applications
Companies Mentioned: Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited; Gilead Sciences Inc.; Merck KgaA; Astellas Pharma Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18637

1. Executive Summary

2. Human Embryonic Stem Cells Market Characteristics

3. Human Embryonic Stem Cells Market Trends And Strategies

4. Human Embryonic Stem Cells Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Human Embryonic Stem Cells Market Size and Growth

5.1. Global Human Embryonic Stem Cells Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Human Embryonic Stem Cells Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Human Embryonic Stem Cells Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Human Embryonic Stem Cells Market Segmentation

6.1. Global Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Totipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
6.2. Global Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Regenerative Medicine
Stem Cell Biology Research
Tissue Engineering
Toxicology Testing
6.3. Global Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Research
Clinical Trials
Other Applications

7. Human Embryonic Stem Cells Market Regional And Country Analysis

7.1. Global Human Embryonic Stem Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Human Embryonic Stem Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Human Embryonic Stem Cells Market

8.1. Asia-Pacific Human Embryonic Stem Cells Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Human Embryonic Stem Cells Market

9.1. China Human Embryonic Stem Cells Market Overview
9.2. China Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Human Embryonic Stem Cells Market

10.1. India Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Human Embryonic Stem Cells Market

11.1. Japan Human Embryonic Stem Cells Market Overview
11.2. Japan Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Human Embryonic Stem Cells Market

12.1. Australia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Human Embryonic Stem Cells Market

13.1. Indonesia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Human Embryonic Stem Cells Market

14.1. South Korea Human Embryonic Stem Cells Market Overview
14.2. South Korea Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Human Embryonic Stem Cells Market

15.1. Western Europe Human Embryonic Stem Cells Market Overview
15.2. Western Europe Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Human Embryonic Stem Cells Market

16.1. UK Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Human Embryonic Stem Cells Market

17.1. Germany Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Human Embryonic Stem Cells Market

18.1. France Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Human Embryonic Stem Cells Market

19.1. Italy Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Human Embryonic Stem Cells Market

20.1. Spain Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Human Embryonic Stem Cells Market

21.1. Eastern Europe Human Embryonic Stem Cells Market Overview
21.2. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Human Embryonic Stem Cells Market

22.1. Russia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Human Embryonic Stem Cells Market

23.1. North America Human Embryonic Stem Cells Market Overview
23.2. North America Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Human Embryonic Stem Cells Market

24.1. USA Human Embryonic Stem Cells Market Overview
24.2. USA Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Human Embryonic Stem Cells Market

25.1. Canada Human Embryonic Stem Cells Market Overview
25.2. Canada Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Human Embryonic Stem Cells Market

26.1. South America Human Embryonic Stem Cells Market Overview
26.2. South America Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Human Embryonic Stem Cells Market

27.1. Brazil Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Human Embryonic Stem Cells Market

28.1. Middle East Human Embryonic Stem Cells Market Overview
28.2. Middle East Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Human Embryonic Stem Cells Market

29.1. Africa Human Embryonic Stem Cells Market Overview
29.2. Africa Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Human Embryonic Stem Cells Market Competitive Landscape And Company Profiles

30.1. Human Embryonic Stem Cells Market Competitive Landscape
30.2. Human Embryonic Stem Cells Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Takeda Pharmaceutical Company Limited
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Gilead Sciences Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck KgaA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Astellas Pharma Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Human Embryonic Stem Cells Market Other Major And Innovative Companies

31.1. Lonza Group
31.2. PerkinElmer Inc.
31.3. R&D Systems
31.4. LifeCell
31.5. Takara Bio Inc.
31.6. ViaCyte Inc.
31.7. PromoCell GmbH
31.8. CellGenix GmbH
31.9. PeproTech Inc.
31.10. Lineage Cell Therapeutics Inc.
31.11. BioTime
31.12. Asterias Biotherapeutics Inc.
31.13. ESI BIO
31.14. STEMCELL Technologies Inc.
31.15. TATAA Biocenter

32. Global Human Embryonic Stem Cells Market Competitive Benchmarking

33. Global Human Embryonic Stem Cells Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Human Embryonic Stem Cells Market

35. Human Embryonic Stem Cells Market Future Outlook and Potential Analysis

35.1 Human Embryonic Stem Cells Market In 2028 - Countries Offering Most New Opportunities
35.2 Human Embryonic Stem Cells Market In 2028 - Segments Offering Most New Opportunities
35.3 Human Embryonic Stem Cells Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer